Cite
HARVARD Citation
Heppner, D. et al. (n.d.). Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study. Lancet infectious diseases. 17 (8), pp. 854-866. [Online].